cancer%20pain
CANCER PAIN
Cancer pain is an unpleasant sensory & emotional experience due to actual or potential tissue damage in patients with cancer.
Effective pain management in cancer patients with pain is an essential part of oncologic management due to increasing evidence of survival.
Pancreatic, head & neck cancer has a high prevalence of cancer pain.
During initial evaluation, follow-ups and new therapy initiation of patients with cancer, it is essential that they will be screened & evaluated for pain.

Cancer%20pain Patient Education

Patient Education

Patient and Family Education

  • Education on the use of analgesics (eg risks and benefits of opioid therapy) and specific instructions about how to deal with uncontrolled pain are part of psychoeducational interventions
  • Education on issues related to cancer pain management is an essential element to effectively manage pain associated with cancer
  • Issues that the patient and the patient’s family/caregiver should addressed to are:
    • Understanding cancer pain
    • Understanding disease processes and their relation to pain
    • How to describe and document pain assessment appropriately
    • Understanding pain management
    • Awareness of the available analgesics
    • Dispelling fears regarding opioid analgesics
    • Accessing help and support
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Oncology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
4 days ago
Ivermectin confers benefits in the treatment of COVID-19, with a recent study showing that its use helps reduce the risk of death especially in patients with severe pulmonary involvement.
4 days ago
Mental health comorbidities are common among patients with type 2 diabetes mellitus and may lead to worse outcomes, a recent study has found.
Roshini Claire Anthony, 13 Nov 2020

Diabetes is a key risk factor for heart failure (HF), which is the leading cause of hospitalization in patients with or without diabetes. SGLT-2* inhibitors (SGLT-2is) have been shown to reduce the risk of hospitalization for HF (HHF) regardless of the presence or absence of diabetes.

Yesterday
Vitamin D deficiency may be a contributing factor to the mortality rate among patients with the novel coronavirus disease (COVID-19), reports a new study.